Skip to content

Effect of Night Time Antihypertensive on Blood Pressure pattern in CKD III-IV: A Randomized Controlled Trial

A Randomized Controlled Trial on the Effect of Night Time Dosing of Antihypertensives on Ambulatory Blood Pressure Monitoring and Cardiovascular and Renal Outcomes in Nondialysis CKD Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/01/011581
Enrollment
50
Registered
2018-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- chronic kidney disease patient

Interventions

Intervention1: Bedtime group: Antihypertensive Dose as per physician discretion to control Blood Pressure Addition of antihypertensive in night time only Oral route only Duration of therapy is 1 yea

Sponsors

IPGMER snd SSKM Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. MDRD eGFR 2. Patients of either sex who were 18 years of age or older are eligible. 3. Patients on antihypertensives taking >= 1 drug(s) of which at least 1 dose is being taken in morning or afternoon 4. Patients should be ambulatory

Exclusion criteria

Exclusion criteria: 1. Suspicion of secondary hypertension, other than CKD. 2. Recent stroke (occurring within the previous 3 months). 3. Recent acute myocardial infarction. 4. Recent hospitalization for heart failure 5. Recent revascularization or planned cardiovascular intervention 6. MDRD eGFR 7. Uncontrolled Hypertension (systolic BP >150 mmHg or diastolic BP >90mmHg) 8. Pregnancy 9. Atrial fibrillation Refusal to undergo repeated follow up visits and ambulatory blood pressure monitoring.

Design outcomes

Primary

MeasureTime frame
1. Conversion to dipper pattern from non dipper in two groups 2. Rate of fall of eGFR in two groups 3. Change in cardiac structure like LV Mass Index and LV ejection fractionTimepoint: Conversion to dipper from non dipper at 3 months Change in eGFR and Cardiac structure at 1 year

Secondary

MeasureTime frame
Changes in 24 hour proteinuriaTimepoint: 1 year

Countries

India

Contacts

Public ContactVaibhav Tiwari

IPGMER

dasgupta.sanjay@rediffmail.com9830082267

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026